Following CPI treatment, the potentially deleterious impact of TRAF2 loss on tumor cell fitness is revealed, where it has potential to enhance anti-tumor T cell activity (Vredevoogd et al., 2019). This evidence concerns the gene TRAF2 and neoplasm.